Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Zimmer Biomet Holdings, Inc. (ZBH) Guidance & Earnings Results

On 2026-08-05 Zimmer Biomet Holdings, Inc. raised guidance: "Reported revenue change raised to 3.9%-4.9% from 2.5%-4.5%; adjusted EPS raised to $8.47-$8.59 from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ZBHZimmer Biomet Holdings, Inc.Follow ZBH — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
18.8B
P/E TTM
23.9
Dividend yield
1.0%
52-week
—
Next earnings
4 Nov, in 11 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
5 Aug 26RaisedReported revenue change raised to 3.9%-4.9% from 2.5%-4.5%; adjusted EPS raised to $8.47-$8.59 from $8.40-$8.55 · full year
28 Apr 26RaisedAdjusted EPS raised from $8.30-$8.45 to $8.40-$8.55; free cash flow expectations raised · full year
5 Nov 25ReaffirmedReported revenue growth 6.7%-7.7%; adjusted EPS $8.10-$8.30 · full year
7 Aug 25RaisedFY2025 reported revenue growth tightened to 6.7%-7.7% from 5.7%-8.2%; constant currency revenue growth to 6.2%-7.2% from 5.7%-7.7%; organic constant currency revenue growth to 3.5%-4.5% from 3.0%-5.0%; adjusted diluted EPS raised to $8.10-$8.30 from $7.90-$8.10. · full year

Zimmer Biomet Holdings, Inc. — questions

What guidance did Zimmer Biomet Holdings, Inc. give?
On 2026-08-05: "Reported revenue change raised to 3.9%-4.9% from 2.5%-4.5%; adjusted EPS raised to $8.47-$8.59 from $8.40-$8.55"
When does Zimmer Biomet Holdings, Inc. report earnings?
Zimmer Biomet Holdings, Inc.'s next earnings report is expected on 2026-11-04.

Every figure on this page comes from Zimmer Biomet Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.